about
Epidemiology of preeclampsia: impact of obesityTranscriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.Insulin and leptin levels in overweight and normal-weight Iranian adolescents: The CASPIAN-III study.Leptin regulates CD16 expression on human monocytes in a sex-specific manner.The associations of adipokines with selected markers of the renin-angiotensinogen-aldosterone system: the multi-ethnic study of atherosclerosis.The Role of Obesity in Preeclampsia.Pharmacological effects of lipid-lowering drugs on circulating adipokines."Role of the adipocyte hormone leptin in cardiovascular diseases - a study from Chennai based Population".Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination SurveyDNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.Leptin levels in obese women with and without type 2 diabetes mellitus.Evaluation of leptin and adiponectin levels in patients with stable angina pectoris.Adipokine Imbalance in the Pericardial Cavity of Cardiac and Vascular Disease PatientsObesity: basic science and medical aspects relevant to anaesthetists.Effect of weight gain on cardiac autonomic control during wakefulness and sleep.Intracellular signalling pathways activated by leptin.Better prognosis in overweight/obese coronary heart disease patients with high plasma levels of leptin.Femoral artery remodeling after aerobic exercise training without weight loss in womenLeptin and cardiovascular disease: response to therapeutic interventionsDecreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice.Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells.Association of plasma leptin concentrations with adiposity measurements in rural Chinese adolescents.Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.Association between leptin gene G-2548A polymorphism with metabolic syndrome.A-FABP mediates adaptive thermogenesis by promoting intracellular activation of thyroid hormones in brown adipocytes.Angiotensin II and the ERK pathway mediate the induction of leptin by mechanical cyclic stretch in cultured rat neonatal cardiomyocytes.Pericoronary adipose tissue: a novel therapeutic target in obesity-related coronary atherosclerosis.Pathway analysis of coronary atherosclerosis.What are the metabolic precursors which increase the risk of pre-eclampsia and how could these be investigated further.Mapping of the leptin binding sites and design of a leptin antagonist.Molecular regulation of the expression of leptin by hypoxia in human coronary artery smooth muscle cellsMature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity.Leptin G-2548A promoter polymorphism is associated with increased plasma leptin and BMI in Brazilian women.Association of adipokines with blood pressure in rural Chinese adolescents.Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction.Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis.Body mass index and blood pressure: where are we now?Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis.Response to deep brain stimulation in the lateral hypothalamic area in a rat model of obesity: in vivo assessment of brain glucose metabolism.
P2860
Q27006497-6FE0165C-0CE5-4ECB-A2BD-95C779E05907Q27853347-E4139EEB-BF0A-432A-9756-EC5D2935B53EQ33821236-8E3F7FCC-AFA1-4B8C-B569-000E66698D08Q33977278-95C50EC7-892D-4352-96F4-1253B5F8DCADQ34622901-0059469D-1FEA-4AEB-BA4D-043685142145Q34691889-FF4673F6-EC37-445C-BBCC-FB97FF44706CQ34853745-62E70EED-4770-49DD-BFDF-88A55C611C98Q34877922-8F878614-F163-44F7-9E89-F6B1815E6FE8Q35164950-7FAB7632-911A-4C21-A170-CCB0430466F0Q35441429-64AA719C-7C2F-4585-A984-610ED1C6F31AQ35584376-73941219-9528-4843-BF1E-DEC3F13CAB77Q35609195-6242A9A7-8D28-4BB7-9FE8-663736AABB51Q35945159-586BF61D-352C-418F-9334-F92BD9E4AC64Q36006923-C478FE35-CF8F-4D83-8F6F-897B9439CED3Q36265022-1B312D0A-7F1A-4EC9-9C2A-4493089918E2Q36311727-2F73C9C9-0255-48F0-8495-70ADF904B5E5Q36334963-931E00AA-E2C4-4768-BF85-0B2612CDBBE5Q36649341-DCC2FBE7-64C2-470A-A8E7-C1E1B5E3A3E5Q36906088-9F3622BE-3BC8-471D-A5E9-A417B9A92D63Q37198354-613B80B4-2CC8-4ECF-9351-D77F28C2E94BQ37264601-C0DCCC95-DF25-468C-8D3C-4763400014E2Q37294077-CA15975E-29E1-4604-9749-C1A9FC3D4D3BQ37341855-DAC5F6DB-67F0-4274-8B6F-FE4F08E3A6C3Q37362218-7A1F9A9D-3AA5-4180-ABB7-A64C8FF6CF58Q37413780-82B851AC-BCB9-4AB8-B5A9-125FC0828CCBQ37622432-008A8DD4-8F63-446D-A9AA-9CC5F9684FB6Q38312360-1391A6B1-2925-4D1D-80A9-78EC3F6D2247Q38373558-BBAE59EB-FFC9-4609-BE62-1D1241284586Q38520286-F4799807-28C7-46D3-A3DF-27A6DB2DEBEDQ38601790-7BCC8439-F3C4-4214-9106-D9005EB9566AQ40542294-6EC94814-3E09-414D-8276-AB54068E6022Q42129333-51754B40-2031-44A8-9EFD-91AF3728E1E4Q42812222-D2EA3879-9C61-4178-931D-1373B32D8706Q43582408-C03F9A31-5BEF-4A60-9201-6681F6F4D20FQ44872185-5CCC1333-3567-4A87-9FAE-13003E9C3824Q45304577-88E99A70-AA8D-4768-B6D5-9A43367D5FDEQ46694915-F1CEFE94-A808-45E7-B3E2-52E56B55FE71Q46911841-4E477F35-274B-49AE-9381-3F7E454A549FQ47628090-FC40833E-9161-4660-AFA8-299BD4B83747Q48733897-9060A53E-AC5A-4B62-8B7D-86B49BB2006F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Leptin, obesity and cardiovascular disease.
@ast
Leptin, obesity and cardiovascular disease.
@en
type
label
Leptin, obesity and cardiovascular disease.
@ast
Leptin, obesity and cardiovascular disease.
@en
prefLabel
Leptin, obesity and cardiovascular disease.
@ast
Leptin, obesity and cardiovascular disease.
@en
P1476
Leptin, obesity and cardiovascular disease.
@en
P2093
Marcelo Lima de Gusmao Correia
P304
P356
10.1097/00041552-200403000-00010
P577
2004-03-01T00:00:00Z